Education
About Us
Working with TipRanks
Follow Us
Biotest AG (DE:BIO3)
:BIO3
BIO3 Stock Chart & Stats
€29.60
-€0.40(-1.46%)
At close: 4:00 PM EST
€29.60
-€0.40(-1.46%)
Day’s Range― - ―
52-Week Range€25.00 - €31.80
Previous CloseN/A
Volume6.32K
Average Volume (3M)894.00
Market Cap
€1.33B
Enterprise ValueN/A
Total Cash (Recent Filing)€119.50M
Total Debt (Recent Filing)€597.20M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Nov 10, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 03, 2025Dividend Yield0.14%
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,785,727
10 Day Avg. Volume432
30 Day Avg. Volume894
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biotest News
BIO3 FAQ
What was Biotest AG’s price range in the past 12 months?
Biotest AG lowest stock price was €25.00 and its highest was €31.80 in the past 12 months.
What is Biotest AG’s market cap?
Biotest AG’s market cap is €1.33B.
When is Biotest AG’s upcoming earnings report date?
Biotest AG’s upcoming earnings report date is Nov 10, 2025 which is in 16 days.
How were Biotest AG’s earnings last quarter?
Currently, no data Available
Is Biotest AG overvalued?
According to Wall Street analysts Biotest AG’s price is currently Overvalued.
Does Biotest AG pay dividends?
Biotest AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.14%. See more information on Biotest AG dividends here
What is Biotest AG’s EPS estimate?
Biotest AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotest AG have?
Biotest AG has 19,785,727 shares outstanding.
What happened to Biotest AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biotest AG?
Currently, no hedge funds are holding shares in DE:BIO3
Biotest Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
Biotest AG
Biotest AG (BIO3) is a biotechnology company based in Germany that specializes in the development and production of immunological and hematological products. The company operates primarily in the biopharmaceutical sector, focusing on therapies for treating immunology and hematology disorders. Biotest is known for its high-quality plasma-derived products, including immunoglobulins, albumins, and coagulation factors, which are used in various therapeutic applications such as autoimmune diseases, immunodeficiencies, and bleeding disorders.
Technical Analysis
Eckert & Ziegler Strahlen und Medizintechnik
―
Evotec
―
Dermapharm Holding SE
―
Medios AG
―
Formycon AG
―